252 related articles for article (PubMed ID: 31793501)
1. Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for
Sivaramakrishnan G; Subramanyam B; Kumar MP; Golla R; Tripathy SP; Mondal R
Int J Mycobacteriol; 2019; 8(4):329-332. PubMed ID: 31793501
[TBL] [Abstract][Full Text] [Related]
2. Bedaquiline susceptibility testing of Mycobacterium tuberculosis in an automated liquid culture system.
Torrea G; Coeck N; Desmaretz C; Van De Parre T; Van Poucke T; Lounis N; de Jong BC; Rigouts L
J Antimicrob Chemother; 2015 Aug; 70(8):2300-5. PubMed ID: 25977401
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs.
Gallo JF; Pinhata JMW; Saraceni CP; de Oliveira RS
J Microbiol Methods; 2017 Aug; 139():168-171. PubMed ID: 28601653
[TBL] [Abstract][Full Text] [Related]
4. A Multilaboratory, Multicountry Study To Determine Bedaquiline MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing.
Kaniga K; Cirillo DM; Hoffner S; Ismail NA; Kaur D; Lounis N; Metchock B; Pfyffer GE; Venter A
J Clin Microbiol; 2016 Dec; 54(12):2956-2962. PubMed ID: 27654337
[TBL] [Abstract][Full Text] [Related]
5. Identification of genetic determinants of bedaquiline resistance in
Umpeleva T; Chetverikova E; Belyaev D; Eremeeva N; Boteva T; Golubeva L; Vakhrusheva D; Vasilieva I
Microbiol Spectr; 2024 Mar; 12(3):e0374923. PubMed ID: 38345388
[TBL] [Abstract][Full Text] [Related]
6. Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study.
Kaniga K; Aono A; Borroni E; Cirillo DM; Desmaretz C; Hasan R; Joseph L; Mitarai S; Shakoor S; Torrea G; Ismail NA; Omar SV
J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31969421
[TBL] [Abstract][Full Text] [Related]
7. Multicenter research on the BACTEC MGIT 960 system for the second-line drugs susceptibility testing of Mycobacterium tuberculosis in China.
Zhao LL; Liang YP; Huang MX; Tan YH; Jiang Y; Chen Y; Liu Z; Gao M; Wei S; Chen Z; Wu J; Jiang Y; Wan KL
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):330-4. PubMed ID: 24091105
[TBL] [Abstract][Full Text] [Related]
8. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
[TBL] [Abstract][Full Text] [Related]
9. No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis.
Pang Y; Jing W; Lu J; Zong Z; Huo F; Dong L; Dai G; Li Y; Huang H; Chu N
Diagn Microbiol Infect Dis; 2019 Aug; 94(4):361-364. PubMed ID: 30876684
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of fully automated BACTEC Mycobacteria Growth Indicator Tube 960 system for susceptibility testing of Mycobacterium tuberculosis.
Bemer P; Palicova F; Rüsch-Gerdes S; Drugeon HB; Pfyffer GE
J Clin Microbiol; 2002 Jan; 40(1):150-4. PubMed ID: 11773109
[TBL] [Abstract][Full Text] [Related]
11. Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
Brown TS; Tang L; Omar SV; Joseph L; Meintjes G; Maartens G; Wasserman S; Shah NS; Farhat MR; Gandhi NR; Ismail N; Brust JCM; Mathema B
Clin Infect Dis; 2024 Feb; 78(2):269-276. PubMed ID: 37874928
[TBL] [Abstract][Full Text] [Related]
12. Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10.
Sturegård E; Ängeby KA; Werngren J; Juréen P; Kronvall G; Giske CG; Kahlmeter G; Schön T
Clin Microbiol Infect; 2015 Feb; 21(2):148.e5-7. PubMed ID: 25640156
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.
Ardito F; Posteraro B; Sanguinetti M; Zanetti S; Fadda G
J Clin Microbiol; 2001 Dec; 39(12):4440-4. PubMed ID: 11724858
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method].
Sinirtaş M; Ozakin C; Gedikoğlu S
Mikrobiyol Bul; 2009 Jul; 43(3):403-9. PubMed ID: 19795615
[TBL] [Abstract][Full Text] [Related]
15. Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.
Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
BMC Infect Dis; 2012 Dec; 12():369. PubMed ID: 23259765
[TBL] [Abstract][Full Text] [Related]
16. Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System.
Demers AM; Venter A; Friedrich SO; Rojas-Ponce G; Mapamba D; Jugheli L; Sasamalo M; Almeida D; Dorasamy A; Jentsch U; Gibson M; Everitt D; Eisenach KD; Diacon AH
J Clin Microbiol; 2016 May; 54(5):1276-81. PubMed ID: 26912751
[TBL] [Abstract][Full Text] [Related]
17. Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.
Keller PM; Hömke R; Ritter C; Valsesia G; Bloemberg GV; Böttger EC
Antimicrob Agents Chemother; 2015 Jul; 59(7):4352-5. PubMed ID: 25941226
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterial growth indicator tube for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin.
Bergmann JS; Woods GL
Diagn Microbiol Infect Dis; 1997 Jul; 28(3):153-6. PubMed ID: 9294706
[TBL] [Abstract][Full Text] [Related]
19. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System.
Rodrigues C; Jani J; Shenai S; Thakkar P; Siddiqi S; Mehta A
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1449-55. PubMed ID: 19017456
[TBL] [Abstract][Full Text] [Related]
20. Reduced Susceptibility of Mycobacterium tuberculosis to Bedaquiline During Antituberculosis Treatment and Its Correlation With Clinical Outcomes in China.
Liu Y; Gao M; Du J; Wang L; Gao J; Shu W; Wang Y; Xue Z; Li L; Pang Y
Clin Infect Dis; 2021 Nov; 73(9):e3391-e3397. PubMed ID: 32667984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
